These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 26398824)
1. Challenging Lung Carcinoma with Coexistent ΔNp63/p40 and Thyroid Transcription Factor-1 Labeling Within the Same Individual Tumor Cells. Pelosi G; Fabbri A; Tamborini E; Perrone F; Testi AM; Settanni G; Busico A; Centonze G; Braidotti P; Bulfamante G; De Braud F; Garassino M; Pastorino U J Thorac Oncol; 2015 Oct; 10(10):1500-2. PubMed ID: 26398824 [No Abstract] [Full Text] [Related]
2. ΔNp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach. Pelosi G; Fabbri A; Bianchi F; Maisonneuve P; Rossi G; Barbareschi M; Graziano P; Cavazza A; Rekhtman N; Pastorino U; Scanagatta P; Papotti M J Thorac Oncol; 2012 Feb; 7(2):281-90. PubMed ID: 22071786 [TBL] [Abstract][Full Text] [Related]
3. Non-small cell lung carcinoma with diffuse coexpression of thyroid transcription factor-1 and ΔNp63/p40. Hayashi T; Takamochi K; Yanai Y; Mitani K; Tomita H; Mogushi K; Suehara Y; Takahashi F; Suzuki K; Saito T; Yao T Hum Pathol; 2018 Aug; 78():177-181. PubMed ID: 29410129 [TBL] [Abstract][Full Text] [Related]
4. A study of ΔNp63 expression in lung non-small cell carcinomas. Nonaka D Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298 [TBL] [Abstract][Full Text] [Related]
5. Non-small cell lung carcinoma with focal coexpression of thyroid transcription factor-1 and Δ Np63/p40: A case report. Terada K; Menju T; Date H; Haga H; Yoshizawa A Thorac Cancer; 2024 Apr; 15(12):1029-1033. PubMed ID: 38478955 [TBL] [Abstract][Full Text] [Related]
6. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway. Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760 [TBL] [Abstract][Full Text] [Related]
7. Utilization of p40 (ΔNp63) with p63 and cytokeratin 5/6 immunohistochemistry in non-small cell lung carcinoma fine-needle aspiration biopsy. Collins BT; Wang JF; Bernadt CT Acta Cytol; 2013; 57(6):619-24. PubMed ID: 24107322 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical Detection of p40 Expression in Lung Cancer Clinical Samples. Nambirajan A; Jain D Methods Mol Biol; 2021; 2279():13-21. PubMed ID: 33683682 [TBL] [Abstract][Full Text] [Related]
9. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis. Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475 [TBL] [Abstract][Full Text] [Related]
10. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens. Loo PS; Thomas SC; Nicolson MC; Fyfe MN; Kerr KM J Thorac Oncol; 2010 Apr; 5(4):442-7. PubMed ID: 20195168 [TBL] [Abstract][Full Text] [Related]
11. p40 (ΔNp63), a lung squamous cell marker, can also be used to label breast myoepithelial cells. Sarda R; Taylor J Arch Pathol Lab Med; 2014 May; 138(5):584. PubMed ID: 24786113 [No Abstract] [Full Text] [Related]
12. [Expression of WWOX protein and its significance in non-small cell lung cancers]. Zhou YL; Xu YJ; Zhang ZX Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):297. PubMed ID: 17760259 [No Abstract] [Full Text] [Related]
13. [Expression of TRIM29 and β-catenin in non-small cell lung cancer and its clinicopathologic significance]. Yang GY; Zhou ZY; Sun RC; Xia YH; Hong JG; Yu MH; Wu GB; Liang JB Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):109-10. PubMed ID: 21426808 [No Abstract] [Full Text] [Related]
14. Immunohistochemical staining with deltaNp63 is useful for distinguishing the squamous cell component of adenosquamous cell carcinoma of the lung. Uramoto H; Yamada S; Hanagiri T Anticancer Res; 2010 Nov; 30(11):4717-20. PubMed ID: 21115930 [TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of secreted proteins of non-small cell lung cancer. Huang LJ; Chen SX; Luo WJ; Jiang HH; Zhang PF; Yi H Ai Zheng; 2006 Nov; 25(11):1361-7. PubMed ID: 17094902 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of the polymeric immunoglobulin receptor in non-small cell lung carcinoma: correlation with dysregulated expression of the transcription factors USF and AP2. Khattar NH; Lele SM; Kaetzel CS J Biomed Sci; 2005; 12(1):65-77. PubMed ID: 15864740 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of biomarkers in primary non-small cell lung cancer and metastatic sites. Gomez-Roca C; Raynaud CM; Penault-Llorca F; Mercier O; Commo F; Morat L; Sabatier L; Dartevelle P; Taranchon E; Besse B; Validire P; Italiano A; Soria JC J Thorac Oncol; 2009 Oct; 4(10):1212-20. PubMed ID: 19687761 [TBL] [Abstract][Full Text] [Related]
18. New predictors of survival for early-stage NSCLC. Sharma SP Lancet Oncol; 2007 Apr; 8(4):288. PubMed ID: 17431952 [No Abstract] [Full Text] [Related]
19. Regulator of G-protein signaling 4: A novel tumor suppressor with prognostic significance in non-small cell lung cancer. Cheng C; Yue W; Li L; Li S; Gao C; Si L; Tian H Biochem Biophys Res Commun; 2016 Jan; 469(3):384-91. PubMed ID: 26640232 [TBL] [Abstract][Full Text] [Related]
20. Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relationship with wxpressions of p53 and Ki-67 proteins. Myong NH J Korean Med Sci; 2003 Aug; 18(4):494-500. PubMed ID: 12923324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]